HDFC Bank Confirms Postal Ballot Notice Dispatch for Director Re-appointment
HDFC Bank has officially confirmed the dispatch of its postal ballot notice dated March 26, 2026, seeking shareholder approval for Dr. Sunita Maheshwari's re-appointment as Independent Director for a three-year term. The bank published newspaper advertisements in Business Standard and Navshakti on March 28, 2026, confirming the notice dispatch. The e-voting period runs from March 28 to April 26, 2026, with NSDL facilitating the remote voting process.

*this image is generated using AI for illustrative purposes only.
HDFC Bank Limited has issued a postal ballot notice dated March 26, 2026, seeking shareholder approval for the re-appointment of Dr. Sunita Maheshwari as an Independent Director. The bank's Board of Directors had earlier approved her re-appointment for a three-year term during a board meeting held on March 26, 2026.
Notice Dispatch Confirmation
The bank has officially confirmed the dispatch of the postal ballot notice through a communication dated March 28, 2026, to stock exchanges under Regulation 30 of SEBI Listing Regulations. The notice was accompanied by newspaper publications in Business Standard (English) and Navshakti (Marathi) on March 28, 2026, ensuring wide dissemination to shareholders.
| Communication Details: | Information |
|---|---|
| Reference Number: | SE/2025-26/214 |
| Dispatch Date: | March 27, 2026 |
| Publication Date: | March 28, 2026 |
| Languages: | English and Marathi |
| Company Secretary: | Ajay Agarwal |
Postal Ballot Process and Timeline
The bank has engaged National Securities Depository Limited (NSDL) to facilitate remote e-voting for shareholders to cast their votes electronically. The postal ballot notice was communicated to stock exchanges on March 27, 2026, under Regulation 30 of SEBI Listing Regulations.
| Parameter: | Details |
|---|---|
| Cut-off Date: | March 20, 2026 |
| E-voting Start: | March 28, 2026 at 10:00 A.M. (IST) |
| E-voting End: | April 26, 2026 at 5:00 P.M. (IST) |
| EVEN Number: | 138927 |
| Scrutinizer: | Mr. B. Narasimhan, M/s. BN & Associates |
Re-appointment Details
Dr. Maheshwari's re-appointment covers a three-year period from March 30, 2026 to March 29, 2029. The appointment requires approval through a Special Resolution by the bank's shareholders via the postal ballot process.
| Director Details: | Information |
|---|---|
| Name: | Dr. Sunita Maheshwari |
| DIN: | 01641411 |
| Position: | Independent Director |
| Term Duration: | 3 years |
| Effective Period: | March 30, 2026 to March 29, 2029 |
| Fixed Remuneration: | ₹30,00,000 per annum |
Professional Background and Expertise
Dr. Maheshwari brings over 30 years of extensive experience spanning the US and India. She is a US Board certified Pediatric Cardiologist who completed her MBBS at Osmania Medical College, followed by post-graduation at AIIMS, Delhi and Yale University.
As a medical entrepreneur, Dr. Maheshwari co-founded the Telerad Group, which encompasses several healthcare technology companies including A-Kal Televerse Private Limited (India's first and largest teleradiology company), Telerad Tech Private Limited, RXDX Healthcare, and Daignostix Services Private Limited.
Board Performance and Attendance
During the current financial year 2025-26, Dr. Maheshwari has attended 16 out of 20 board meetings as of the notice date. She was paid ₹44,00,000 as sitting fees for attending board and committee meetings during FY 2025-26, and is eligible for a fixed remuneration of ₹30,00,000 for the year.
Voting Process and Compliance
Shareholders whose names appear in the Register of Members as on the cut-off date of March 20, 2026, are eligible to vote. The notice has been uploaded on the bank's website and NSDL's e-voting platform. Results will be declared within two working days from the end of the e-voting period and communicated to stock exchanges.
Historical Stock Returns for HDFC Bank
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.06% | -1.33% | +5.47% | -22.20% | -18.41% | +11.00% |
How might Dr. Maheshwari's healthcare technology expertise influence HDFC Bank's digital transformation and fintech initiatives over the next three years?
What impact could the board composition changes have on HDFC Bank's strategic direction in emerging sectors like healthcare financing?
Will HDFC Bank leverage Dr. Maheshwari's teleradiology and healthcare entrepreneurship experience to expand into medical lending or health-tech partnerships?


































